Research & Development
Sherlock Biosciences Forges Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2
12 August 2020 - - US-based engineering biology company Sherlock Biosciences has forged a research collaboration with Dartmouth-Hitchcock Health to launch a clinical study of the Sherlock CRISPR SARS-...
Baxter Obtains US FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic
12 August 2020 - - US-based acute care specialist Baxter International Inc. (NYSE: BAX) has received Emergency Use Authorizations from the US Food and Drug Administration for the company's HF20 S...
Chrysalis BioTherapeutics Receives Additional Funding from the National Institutes of Health for COVID-19 Therapeutic Development
12 August 2020 - - US-based biotechnology company Chrysalis BioTherapeutics, Inc., which is developing regenerative drugs that target vascular endothelial and progenitor cells,

The Natio...
Biodesix to Provide COVID-19 Testing for Colorado State University Campus
12 August 2020 - - US-based diagnostic company Biodesix, Inc plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begi...
India Globalization Capital wins FDA approval to begin Phase 1 human trial study of investigational cannabinoid formulation in patients with Alzheimer's disease
12 August 2020 - Life science company India Globalization Capital (NYSE American:IGC) reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) to launch a Phase 1 hum...
Dr. Reddy's Laboratories Launches Generic Version of Ciprodex Otic Suspension, USP in the US Market
12 August 2020 - - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP...
Related Headlines

Gilead Submits New Drug Application to US Food and Drug Administration for Veklury for the Treatment of COVID-19

Noninvasive Ventilator Obtains EUA from the FDA for At-Home Use for the Treatment of COVID-19

Dr Reddy's Laboratories announces first-to-market generic Ciprofloxacin 0.3% and Dexamethasone USP in the US

Ethos Laboratories awarded US FDA's EUA for SARS-CoV-2 MALDI-TOF Assay

US FDA Approves Genentech's Evrysdi for Treatment of Spinal Muscular Atrophy in Adults and Children 2 Months and Older

FDA Clears Appili Therapeutics to Expand its Phase 2 Clinical Trial of Favipiravir for the Potential Prevention of COVID-19 at US Long-Term Care Facilities

Omeros Touts Results of Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome

Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil

Certara Launches New COVID-19 Biosimulation Platform and Key Updates to Its Quantitative Systems Pharmacology Technology Platforms

The US FDA provides update of COVID-19 actions

Upsher-Smith Laboratories signs collaboration agreement with AmbioPharm

US FDA approves PTC Therapeutics' Evrysdi

Cutting Edge Laser Technologies publishes case report in American Journal of Case Reports of Supportive Photobiomodulation Therapy in COVID-19 patients

ViiV Healthcare Wins FDA Nod of Expanded Dovato Indication

Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by Blenrep FDA Approval